Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
AstraZeneca
Moodys
Boehringer Ingelheim
Medtronic

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Apothecon Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Apothecon
US Patents:0
Tradenames:78
Ingredients:47
NDAs:114

Drugs and US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon PENTIDS '200' penicillin g potassium TABLET;ORAL 062155-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Apothecon TRIMOX amoxicillin CAPSULE;ORAL 062152-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061901-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Apothecon ATENOLOL atenolol TABLET;ORAL 073318-001 Mar 20, 1992 DISCN No No   Start Trial   Start Trial
Apothecon LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 075223-003 Nov 20, 1998 DISCN No No   Start Trial   Start Trial
Apothecon VEETIDS '500' penicillin v potassium TABLET;ORAL 062156-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Apothecon PRINCIPEN ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 061394-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 4,105,776   Start Trial
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-001 Approved Prior to Jan 1, 1982 3,819,635   Start Trial
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 4,217,347   Start Trial
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 4,217,347   Start Trial
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 4,217,347   Start Trial
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 4,105,776   Start Trial
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-002 Approved Prior to Jan 1, 1982 3,819,635   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Medtronic
Mallinckrodt
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.